Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

NCT04023227 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

922

Enrollment

INDUSTRY

Sponsor class

Conditions

Chagas Disease
Heart Failure

Interventions

DRUG: Sacubitril/valsartan
DRUG: Enalapril

Sponsor

Novartis Pharmaceuticals